Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study
ABvac40 主动免疫疗法治疗轻度认知障碍或极轻度阿尔茨海默病患者的安全性、耐受性、免疫原性和疗效:一项随机、双盲、安慰剂对照的 II 期研究
期刊:Alzheimers & Dementia
影响因子:11.1
doi:10.1002/alz.70776
Pascual-Lucas, María; Lacosta, Ana María; Montañés, María; Canudas, Jesús; Loscos, Jorge; Monleón, Inmaculada; Allué, José Antonio; Sarasa, Leticia; Fandos, Noelia; Romero, Judith; Sarasa, Manuel; Torres, Mireia; Whyms, Dermot; Terencio, Jose; Piñol-Ripoll, Gerard; Boada, Mercè